Product Information
RISPERDAL 1 MG/ML SOLUTION is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $5.2829 per ML under NDC 50458030503. Its NADAC has been published 345 times since Nov 28, 2013.
FDA first approved this application on Jun 10, 1996. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the risperidone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 mg/mL
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458030503
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
RISPERIDONEApproval Type
New Drug (NDA)
FDA Application
NDA020588FDA Approved
6/10/1996
TE Code
AA
On Market Since
6/10/1996
Pharmacological Classes
Price Statistics
The NADAC for RISPERDAL 1 MG/ML SOLUTION has been published 345 times since Nov 28, 2013, and over the history we have for it it has declined 28.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.2829 per ML |
|---|---|
| All-time high | $12.1563 (Sep 15, 2021) |
| All-time low | $5.2349 (Dec 17, 2025) |
| 52-week high | $5.2829 |
| 52-week low | $5.2349 |
| Median price | $8.0668 |
| Average price | $7.9954 |
| Largest weekly change | -56.8% (Apr 17, 2024) |
| Weeks tracked | 345 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 91% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Janssen Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
risperidone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RISPERDAL 1 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for RISPERDAL 1 MG/ML SOLUTION, manufactured by Janssen Pharmaceuticals Inc., is $5.2829 per ML (NDC 50458030503), effective Sep 30, 2026.
How has the price of RISPERDAL 1 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for RISPERDAL 1 MG/ML SOLUTION has declined 28.0%. It has been tracked across 345 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RISPERDAL 1 MG/ML SOLUTION?
Since Nov 28, 2013, the NADAC for RISPERDAL 1 MG/ML SOLUTION has ranged from a low of $5.2349 (Dec 17, 2025) to a high of $12.1563 (Sep 15, 2021), with a median of $8.0668 per ML.
Are there cheaper alternatives to RISPERDAL 1 MG/ML SOLUTION?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RISPERIDONE 1 MG/ML SOLUTION, is $0.4724 per ML — about 91% below RISPERDAL 1 MG/ML SOLUTION.
Who manufactures RISPERDAL 1 MG/ML SOLUTION?
RISPERDAL 1 MG/ML SOLUTION (NDC 50458030503) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.